B3GNT7

Chr 2

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7

Also known as: beta3GnT7

Enables N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity. Involved in keratan sulfate proteoglycan biosynthetic process. Predicted to be located in membrane. Predicted to be active in Golgi membrane. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
6
Pubs (1 yr)
P/LP submissions
P/LP missense
0.49
LOEUF
Mechanism
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.49LOEUF
pLI 0.706
Z-score 2.79
OE 0.16 (0.060.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.19Z-score
OE missense 0.80 (0.710.89)
221 obs / 276.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.16 (0.060.49)
00.351.4
Missense OE?0.80 (0.710.89)
00.61.4
Synonymous OE?1.04
01.21.6
LoF obs/exp: 2 / 12.7Missense obs/exp: 221 / 276.7Syn Z: -0.40

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

B3GNT7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →